Data / Form D filings / Airway Therapeutics, Inc.
Airway Therapeutics, Inc.: Form D filings
Airway Therapeutics, Inc., a biotechnology company in Marietta, GA, filed 2 Form D notices with the SEC between 2018 and 2026. The latest, on September 9, 2026, reports $43.5 million sold of a $50.6 million offering to 116 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1205 JOHNSON FERRY RD. SUITE 136, BOX 518, Marietta, GA, 30068
- Phone
- (513) 770-9630
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1733867
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | New notice | $50,584,517 | $43,496,282 | $7,088,235 | 116 | Aug 10, 2026 | sec.gov |
| Mar 13, 2018 | New notice | $11,000,000 | $10,930,967 | $69,033 | 39 | Mar 1, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marc Salzberg | Executive Officer, Director | Chairman and Chief Executive Officer |
| Alan Wolk | Executive Officer, Director | Chief Financial Officer, Chief Operating Officer, Treasurer and Secretary |
| Doug Loftus | Director | |
| Elise Scroggs Panayotopoulous | Director | |
| Joe Todicsco | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Sep 7, 2026 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Airway Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.